Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash & Equivalents: 2018

Historic Cash & Equivalents for DiaMedica Therapeutics (DMAC) over the last 1 years, with Dec 2018 value amounting to $16.8 million.

  • DiaMedica Therapeutics' Cash & Equivalents rose 21.63% to $4.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $4.7 million, marking a year-over-year increase of 21.63%. This contributed to the annual value of $16.8 million for FY2018, which is N/A change from last year.
  • According to the latest figures from FY2018, DiaMedica Therapeutics' Cash & Equivalents is $16.8 million.
  • DiaMedica Therapeutics' 5-year Cash & Equivalents high stood at $16.8 million for FY2018, and its period low was $16.8 million during FY2018.
  • For the 1-year period, DiaMedica Therapeutics' Cash & Equivalents averaged around $16.8 million, with its median value being $16.8 million (2018).